-
Sparkling flavoured water supporting UK diabetes charities
I was recently travelling on a British Airways flight and saw a drink called Loveau listed in the in-flight menu. What caught my attention was the fact that money from every can sold is donated to UK Diabetes charities. Loveau is an all-natural, zero carbs, zero calories, sparkling water that’s infused with natural fruit essence and free from sugar or sweeteners. The idea for making a drink free from sugar or sweeteners came when Ollie (son of one of the founders) was diagnosed with Type 1 diabetes at the age of 8. Ollie’s Dad, Simon, along with his colleagues Ian and Ade, decided to make a great alternative to sugary…
-
A new needle free and non-invasive Continuous Glucose Monitor (CGM) is launching soon
We are really interested in seeing this development of a needle free and non-invasive Continuous Glucose Monitor (CGM). Nemaura Medical is a medical technology company developing sugarBEAT® which is a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) SugarBEAT® consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings every five minutes for periods up to 24 hours. – SugarBEAT® market launch due sometime this year (2018) initially in United Kingdom. – SugarBEAT® daily price expected to be comparable to cost of using glucose meters and strips. – SugarBEAT’s® 24 hour patch wear time allows for greater flexibility, with users able to…
-
Pharmaceutical giant Novo Nordisk working on developing glucose responsive insulins.
A graduate who co-founded a company while studying at university could become a multi-millionaire after it was sold in a deal potentially worth £623m. Dr Harry Destecroix, 31, co-founded Ziylo while studying for his PhD at the University of Bristol four years ago. It created a new technology which can be developed to treat diabetes more effectively. Pharmaceutical giant Novo Nordisk’s purchase means it now has full rights to develop glucose responsive insulins. https://www.bbc.co.uk/news/uk-england-bristol-45268904
-
Unique inflammation patterns observed in people with type 1 diabetes
US researchers have discovered that people with type 1 diabetes have unique inflammation patterns, which could help lead to treatments aimed at preventing complications. Long-term high blood sugar levels in people with type 1 diabetes appears to result in chronic inflammation, researchers say, which can impair organs, nerves and blood vessels. Scientists from Augusta University and Georgia Research Alliance Eminent Scholar in Genomic Medicine set about examining markers of inflammation in 89 people with diabetes-related kidney disease as well as 483 people with type 1 diabetes but without kidney problems. https://www.diabetes.co.uk/news/2018/mar/unique-inflammation-patterns-observed-in-people-with-type-1-diabetes-95983495.html
-
Theresa May revealed she had Type 1 diabetes while she was home secretary
Mrs May revealed she had Type 1 diabetes while she was home secretary, and keeping it under control meant injecting herself with insulin up to five times a day. ‘When I was diagnosed with diabetes, the NHS was there for me,’ she said. ‘Skilled and compassionate, helping me every step of the way to manage my condition and live a normal life. ‘I rely on the NHS every day and I am eternally grateful to them.’ Read more: http://www.dailymail.co.uk/news/article-5513013/Theresa-says-relies-NHS-diabetes.html#ixzz5A2ViByRJ